These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37699688)

  • 21. The Recent Progress China Has Made in Green Mine Construction, Part I: Mining Groundwater Pollution and Sustainable Mining.
    Li S; Yu L; Jiang W; Yu H; Wang X
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current status and prospect of DNA synthesis in industrial biotechnology].
    Feng M; Wang L; Wang B; Tian H; Bai X; Liu Y; Xia H
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4115-4131. PubMed ID: 37699681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scalable enantioselective processes for chiral pharmaceutical intermediates.
    Iida T; Mase T
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):834-51. PubMed ID: 12478715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The spatial spillover effect of environmental regulation on the total factor productivity of pharmaceutical manufacturing industry in China.
    Wu Q; Li Y; Wu Y; Li F; Zhong S
    Sci Rep; 2022 Jul; 12(1):11642. PubMed ID: 35804005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesizing Chiral Drug Intermediates by Biocatalysis.
    Jiang W; Fang B
    Appl Biochem Biotechnol; 2020 Sep; 192(1):146-179. PubMed ID: 32323141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synthetic biology: from "build-for-use" to commercialization].
    Zhao G
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4001-4011. PubMed ID: 37699671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advances of enzymes in the applications of disease treatment and drug preparation].
    Zhou R; Liu X; Zeng B; Jiang W; Zhang G
    Sheng Wu Gong Cheng Xue Bao; 2021 Jul; 37(7):2256-2271. PubMed ID: 34327893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advances in microbial synthesis of plant natural products].
    Bi H; Liu X; Li Q; Cheng J; Zhuang Y; Wang D; Dai Z; Jiang H; Liu T; Zhang X
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4263-4282. PubMed ID: 37699689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocommodity Engineering.
    Lynd LR; Wyman CE; Gerngross TU
    Biotechnol Prog; 1999 Oct; 15(5):777-793. PubMed ID: 10514248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the environmental properties and resource utilization of construction waste in Beijing-Tianjin-Hebei region.
    Hu S; Ren F; Jia J; Cui C; Guo C; Cui N; Ma L; Si H; Lu T; Liu G; Zhang B; Liu J
    Environ Sci Pollut Res Int; 2022 Oct; ():. PubMed ID: 36194321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineering a more sustainable world through catalysis and green chemistry.
    Sheldon RA
    J R Soc Interface; 2016 Mar; 13(116):. PubMed ID: 27009181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzyme-based solutions for textile processing and dye contaminant biodegradation-a review.
    Chatha SAS; Asgher M; Iqbal HMN
    Environ Sci Pollut Res Int; 2017 Jun; 24(16):14005-14018. PubMed ID: 28401390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient methods for the synthesis of chiral 2-oxazolidinones as pharmaceutical building blocks.
    Okuno K; Nishiyori R; Abe K; Mori T; Shirakawa S
    Chirality; 2022 Jul; 34(7):915-924. PubMed ID: 35488466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Past, present, and future industrial biotechnology in China.
    Li Z; Ji X; Kan S; Qiao H; Jiang M; Lu D; Wang J; Huang H; Jia H; Ouyuang P; Ying H
    Adv Biochem Eng Biotechnol; 2010; 122():1-42. PubMed ID: 20582527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New opportunities for biocatalysis: driving the synthesis of chiral chemicals.
    Zheng GW; Xu JH
    Curr Opin Biotechnol; 2011 Dec; 22(6):784-92. PubMed ID: 21783357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated operation of continuous chromatography and biotransformations for the generic high yield production of fine chemicals.
    Bechtold M; Makart S; Heinemann M; Panke S
    J Biotechnol; 2006 Jun; 124(1):146-62. PubMed ID: 16516996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rational design and applications of industrial proteins].
    Qu G; Yuan B; Sun Z
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4068-4080. PubMed ID: 37699678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustainable production of pharmaceutical, nutraceutical and bioactive compounds from biomass and waste.
    Espro C; Paone E; Mauriello F; Gotti R; Uliassi E; Bolognesi ML; Rodríguez-Padrón D; Luque R
    Chem Soc Rev; 2021 Oct; 50(20):11191-11207. PubMed ID: 34553208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perspectives and industrial potential of PGA selectivity and promiscuity.
    Grulich M; Štěpánek V; Kyslík P
    Biotechnol Adv; 2013 Dec; 31(8):1458-72. PubMed ID: 23863475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.